Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Hawkins

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Academic Medicine : Journal of the Association of American Medical Colleges|August 1, 2019
Reconsidering Basic: Integrating Social and Behavioral Sciences to Support LearningZarah K Chaudhary, Maria Mylopoulos, Rachael Barnett, et al.
American Journal of Infection Control|August 3, 2005
Focus group data as a tool in assessing effectiveness of a hand hygiene campaignMcKinley Thomas, Wanda Gillespie, Janis Krauss, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2005
Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancerWilliam J Gradishar, Sergei Tjulandin, Neville Davidson, et al.
Blood|February 20, 2015
An open-label phase 2 trial of entospletinib (GS-9973), a selective spleen tyrosine kinase inhibitor, in chronic lymphocytic leukemiaJeff Sharman, Michael Hawkins, Kathryn Kolibaba, et al.
Pediatric Clinics of North America|November 2, 2020
Subsequent Primary Neoplasms: Risks, Risk Factors, Surveillance, and Future ResearchMichael Hawkins, Smita Bhatia, Tara O Henderson, et al.
General Hospital Psychiatry|April 6, 2018
Suicide deaths by intentional self-poisoning in people with cardiovascular diseaseMichael Hawkins, Ayal Schaffer, Mark Sinyor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2005
Comparative preclinical and clinical pharmacokinetics of a cremophor-free, nanoparticle albumin-bound paclitaxel (ABI-007) and paclitaxel formulated in Cremophor (Taxol)Alex Sparreboom, Charity D Scripture, Vuong Trieu, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|November 30, 2004
[A tolerability study of A cremophor-free albumin bound nanoparticle paclitaxel intravenously administered in patients with advanced solid tumor]Xiao-Yu Teng, Zhong-Zhen Guan, Zhi-Wen Yao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2006
Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxelNeil Desai, Vuong Trieu, Zhiwen Yao, et al.
The Journal of Trauma|October 24, 2002
A comparison of the abilities of nine scoring algorithms in predicting mortalityJ Wayne Meredith, Gregory Evans, Patrick D Kilgo, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Academic Medicine : Journal of the Association of American Medical Colleges|August 1, 2019
Reconsidering Basic: Integrating Social and Behavioral Sciences to Support LearningZarah K Chaudhary, Maria Mylopoulos, Rachael Barnett, et al.
American Journal of Infection Control|August 3, 2005
Focus group data as a tool in assessing effectiveness of a hand hygiene campaignMcKinley Thomas, Wanda Gillespie, Janis Krauss, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2005
Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancerWilliam J Gradishar, Sergei Tjulandin, Neville Davidson, et al.
Blood|February 20, 2015
An open-label phase 2 trial of entospletinib (GS-9973), a selective spleen tyrosine kinase inhibitor, in chronic lymphocytic leukemiaJeff Sharman, Michael Hawkins, Kathryn Kolibaba, et al.
Pediatric Clinics of North America|November 2, 2020
Subsequent Primary Neoplasms: Risks, Risk Factors, Surveillance, and Future ResearchMichael Hawkins, Smita Bhatia, Tara O Henderson, et al.
General Hospital Psychiatry|April 6, 2018
Suicide deaths by intentional self-poisoning in people with cardiovascular diseaseMichael Hawkins, Ayal Schaffer, Mark Sinyor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2005
Comparative preclinical and clinical pharmacokinetics of a cremophor-free, nanoparticle albumin-bound paclitaxel (ABI-007) and paclitaxel formulated in Cremophor (Taxol)Alex Sparreboom, Charity D Scripture, Vuong Trieu, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|November 30, 2004
[A tolerability study of A cremophor-free albumin bound nanoparticle paclitaxel intravenously administered in patients with advanced solid tumor]Xiao-Yu Teng, Zhong-Zhen Guan, Zhi-Wen Yao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2006
Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxelNeil Desai, Vuong Trieu, Zhiwen Yao, et al.
The Journal of Trauma|October 24, 2002
A comparison of the abilities of nine scoring algorithms in predicting mortalityJ Wayne Meredith, Gregory Evans, Patrick D Kilgo, et al.
Pageof 4